© Yposkesi
Amyl Therapeutics receives additional €5M funding to advance therapeutic platform
Corteria
Visibility and market recognition for a biopharma company
SeaBeLife raises €1.2 M ($1.28 M) from iXLife fund and historical investors
© David Levron
EverImmune secures €3.5 million in financing from Bpifrance
Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases
© CORTERIA
ABL enters seven-year multimillion dollar contract with NIH for Diagnostics Preclinical Services program
©-Gary-Landsman.jpg
Yposkesi inaugurates €60M biomanufacturing site for cell and gene therapies
© Focus Kpture